Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 06 Jun 2023 16:47 CEST |
BERGENBIO | BerGenBio - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 05 Jun 2023 22:11 CEST |
BERGENBIO | BerGenBio Announces Data from Bemcentinib Trial in Mesothelioma Presented at ASCO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2023 18:19 CEST |
BERGENBIO | BerGenBio to Participate in Investor Webcast and Q&A | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2023 13:28 CEST |
BERGENBIO | BerGenBio ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 May 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Commencement of the subscription period for the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 May 2023 14:41 CEST |
BERGENBIO | BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue | 20103010 Biotechnology | Prospectus / admission document |
| 25 May 2023 08:04 CEST |
BERGENBIO | Shareholder disclosure | 20103010 Biotechnology | Major shareholding notifications |
| 25 May 2023 07:00 CEST |
BERGENBIO | BerGenBio Announces Abstracts Accepted for Presentation at 2023 ASCO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2023 20:12 CEST |
BERGENBIO | Mandatory notification of trade by related party to Primary Insiders | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 May 2023 07:00 CEST |
BERGENBIO | BGBIO - Ex. subscription rights today | 20103010 Biotechnology | Ex Date |
| 22 May 2023 18:01 CEST |
BERGENBIO | BerGenBio ASA: Annual general meeting held | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2023 12:05 CEST |
BERGENBIO | BerGenBio ASA - Updated key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2023 12:00 CEST |
BERGENBIO | BERGENBIO ASA - Terms of the partially underwritten rights issue | 20103010 Biotechnology | Inside information |
| 09 May 2023 18:14 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 May 2023 18:14 CEST |
BERGENBIO | BerGenBio to hold business update conference call | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 15:00 CEST |
BERGENBIO | BERGENBIO ASA: Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 13:01 CEST |
BERGENBIO | BERGENBIO ASA: Board approval of 2022 Annual Financial Statement and Annual Report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Apr 2023 17:56 CEST |
BERGENBIO | BerGenBio ASA - Key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:49 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:48 CEST |
BERGENBIO | BerGenBio ASA: Proposed partially underwritten rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:48 CEST |
BERGENBIO | BerGenBio ASA: Foreslår delvis garantert fortrinnsrettsemisjon | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 18 Apr 2023 07:00 CEST |
BERGENBIO | BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Mar 2023 20:39 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Mar 2023 08:00 CEST |
BERGENBIO | BerGenBio to Present at Upcoming Scientific Conferences | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Mar 2023 07:00 CET |
BERGENBIO | BerGenBio to Present at the Carnegie Nordic Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Mar 2023 11:00 CET |
BERGENBIO | BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2023 07:00 CET |
BERGENBIO | BerGenBio Reports Fourth Quarter 2022 Financial Results and Provides Business Update | 20103010 Biotechnology | Inside information |
| 15 Feb 2023 17:00 CET |
BERGENBIO | BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients | 20103010 Biotechnology | Inside information |
| 02 Feb 2023 07:00 CET |
BERGENBIO | BerGenBio Announces the Establishment of Oncology Scientific Advisory Board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Feb 2023 07:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to fourth quarter 2022 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Dec 2022 08:58 CET |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |